Navigation Links
Novelos Therapeutics to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
Date:6/13/2011

MADISON, Wis., June 13, 2011 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCBB: NVLT), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that Harry S. Palmin, President and CEO of Novelos, will present at the 5th  Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on Thursday, June 16, 2011, at 11:30 a.m. Eastern time.

The webcast of the Novelos presentation may be accessed at www.novelos.com

The webcast archive will be available for 90 days following the presentation.

This day-long virtual conference event includes 30-minute presentations with accompanying slides from nine industry leaders, and begins at 9:00 a.m. Eastern time.  The event may be accessed at the PrecisionIR event site www.vcall.com/CustomEvent/lipper/index.asp

About Novelos Therapeutics, Inc.We are a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer. We currently have three cancer-targeted compounds, which are selectively taken up and retained in cancer cells (including cancer stem cells) versus normal cells.  Thus, our therapeutic compounds directly kill cancer cells while minimizing harm to normal cells.  This offers the potential for a paradigm shift in cancer therapy – efficacy versus all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse.  LIGHT is a small-molecule cancer imaging agent.  We believe LIGHT has first-in-class potential and expect it to enter Phase 1/2 clinical trials in the third quarter of this year.  HOT is a small-molecule, broad-spectrum, cancer-targeted molecular radiotherapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells.  We believe HOT also has first-in-class potential, and we expe
'/>"/>

SOURCE Novelos Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nonconformity of NOV002 Used in Phase 3 NSCLC Trial Sponsored by Novelos Therapeutics, Inc to NOV002 (Glutoxim(R)), Used in Phase 1/2 NSCLC and all Previous Trials
2. Grifols Announces Combined Operations With Talecris to Begin a New Era as a Global Leader of Life-Saving Plasma Therapeutics
3. Healthpoint Biotherapeutics to Present at Upcoming Investment Conferences
4. Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China
5. Precision Therapeutics Presents Clinical Study Emphasizing the Role of ChemoFx® in Directing Chemotherapy in Gynecological Cancers
6. Precision Therapeutics Demonstrates Utility of Multi-Gene Predictors in Predicting Chemotherapy Response for Breast Cancer Patients
7. Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33
8. Echo Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference
9. Orexigen® Therapeutics Provides a Regulatory Update on Contrave® NDA
10. Goodwin Biotechnology Announces a Collaboration With Alethia Biotherapeutics
11. Serina Therapeutics, Inc. Closes $9.5 Million Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 ... and segments the concerned market with analysis and ... $261.8 million in 2014, and is estimated to ... of 19.3% from 2014 to 2019. ... Simulation Market for an analysis of industry trends ...
(Date:6/2/2015)... , June 2, 2015 BioDelivery Sciences International, Inc. ... the presentation by Dr. Mark A. Sirgo , President ... 2:30 PM Eastern time. Jefferies 2015 Global Healthcare ... Hyatt, New York City , NY ... accessed at www.bdsi.com .  For those who are not ...
(Date:6/2/2015)... -- Only a quarter of physicians who prescribe opioids say ... them to, according to new survey results released by ... and myCME , Haymarket Medical Education,s global medical ... director of BUSM,s Safe and Competent Opioid Prescribing ... a critical need for provider education addressing this issue. ...
Breaking Medicine Technology:North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 3BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 3Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2
... ... Jolla-, ... /PRNewswire-,FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a,biopharmaceutical company ... organization, today announced,that an agreement has been executed licensing classes of ...
... The Quigley,Corporation (Nasdaq: QGLY ) announced positive ... subsidiary, Quigley Pharma Inc., which was,conducted in chickens ... The compound was administered to chicks that had ... from the study indicated,that QR448(a) is efficacious against ...
Cached Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5
(Date:6/2/2015)... Prussia, PA (PRWEB) June 02, 2015 ... Outsourcing solutions for health plans in the Medicare Advantage, ... participation as a sponsor and exhibitor at AHIP’s Institute ... America’s Health Insurance Plans. The conference will be held ... exhibition booth, #1303, will offer opportunities for attendees to ...
(Date:6/2/2015)... Dallas, TX, USA (PRWEB) June 02, 2015 ... and microsystems, is deploying its growth strategy to benefit ... on BioMEMS: “In Yole Développement’s May 2015 Status of ... market will grow sharply and reach $6.6B in 2020,” ... at Yole Développement . , The analyst adds ...
(Date:6/2/2015)... MedPro Healthcare Staffing, the leading provider of temporary ... the worldwide release of the MedPro Top Jobs app, ... find best jobs that fit their needs. , According ... 10 job seekers report they’re likely to use a ... Top Jobs app gives its users 24/7 mobile access ...
(Date:6/2/2015)... June 02, 2015 Claflin Medical ... has announced the acquisition of RSI Equipment, ... effective May 29th, 2015. , With CME’s recent merger ... latest acquisition joins three premier organizations which specialize in ... and healthcare facilities. By combining forces, they now cover ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 MAP Health ... and revenue cycle management for addiction treatment facilities, announced ... Vice President of Marketing. Mr. Smith will be responsible ... the awareness and visibility of MAP’s core message, products ... was the Marketing Manager at Cottonwood Financial in Irving, ...
Breaking Medicine News(10 mins):Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2Health News:MedPro Healthcare Staffing Launches New MedPro Top Jobs App To Facilitate Job Search For Healthcare Professionals 2Health News:Claflin Medical Equipment (CME) Announces Acquisition of RSI Equipment, Inc. 2Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2
... understanding of the evolution and spread of viruses like H5N1, ... a consortium, where all// information about the avian influenza will ... on Sharing Avian Influenza Data (GISAID) was announced in ... that was signed by 70 scientists and health officials. Dr. ...
... a vaccine against pneumococcal disease will be introduced for the ... 50 babies and small children a year and prevnt// illness ... national childhood immunisation programme. all babies will be vaccinated against ... months,from Sept.4. Apart from that, in a catch-up programme, infants ...
... analytical capabilities of high-tech laboratory tools, like computers, their ... they have// developed a second generation "lab on a ... first time rapidly and reliably sequences all mitochondrial DNA, ... Diagnostics. Mitochondria which are the energy-producing organelles in cells, ...
... tools such as computers with greater analytical capacities are ... generation "lab on a silicon chip" called the MitoChip ... mitochondrial DNA quickly and reliably. Their report will be ... Molecular Diagnostics. ,The mitochondria have their own ...
... a coordinated global plan, especially in developing countries to ... HIV/AIDS-related cases. ,57 countries, mostly in sub-Saharan ... facing acute shortage. Over 4 million workers are needed ... Train, Retain’ is an essential part of its effort ...
... latest example of growing online interaction between Britain and ... hour for online tuition on various subjects from teachers ... have been receiving such one-to-one tuition using Internet telephony ... employs teachers who work in shifts. ,While ...
Cached Medicine News:Health News:Global avian flu database 2Health News:Global avian flu database 3Health News:Global avian flu database 4Health News:Immunisation programme to include vaccine against Pneumococcal disease 2Health News:High -tech Mitochondrial DNA Sequencing Tool Updated 2Health News:High -tech Mitochondrial DNA Sequencing Tool Updated 3Health News:High -tech Mitochondrial DNA Sequencing Tool Updated 4Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 2Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 3Health News:MitoChip v2.0 – the new Mitochondrial DNA sequencing too 4Health News:British Pupils Opt for Online Tuition from India 2
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z37,160-2) ... assistance. Color: colour-coded ...
... These 3mL PYREX volumetric pipets ... tolerances in accordance with ASTM ... pipet is individually serialized and ... Identification and Capacity, traceable to ...
... disposable lever action skin stapler ... that is designed to provide ... work from your normal vantage ... available in four configurations: 35 ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
Medicine Products: